Cargando…
Endothelial‐protective effects of a G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist, SAR247799, in type‐2 diabetes rats and a randomized placebo‐controlled patient trial
AIMS: SAR247799 is a G‐protein‐biased sphingosine‐1 phosphate receptor‐1 (S1P(1)) agonist designed to activate endothelial S1P(1) and provide endothelial‐protective properties, while limiting S1P(1) desensitization and consequent lymphocyte‐count reduction associated with higher doses. The aim was t...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247405/ https://www.ncbi.nlm.nih.gov/pubmed/33125753 http://dx.doi.org/10.1111/bcp.14632 |